A detailed history of Macroview Investment Management LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Macroview Investment Management LLC holds 361 shares of VXRT stock, worth $223. This represents 0.0% of its overall portfolio holdings.

Number of Shares
361
Previous 361 -0.0%
Holding current value
$223
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 03, 2021

BUY
$5.64 - $23.33 $2,036 - $8,422
361 New
361 $2,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $78.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.